The prevalence of inflammatory bowel disease in U.S. children under 20 is increasing, with over 100,000 affected, revealing critical public health concerns.
Aerie Pharmaceuticals Inc Patent: Ocular Disorder Treatment with Amino Isoquinolinyl Amide Compounds
Share this article According to GlobalData’s company profile on Aerie Pharmaceuticals, was a key innovation area identified from patents. A recently granted patent (Publication Number: